Paper39411684
Inhalable and bioactive lipid-nanomedicine based on bergapten for targeted acute lung injury therapy via orchestrating macrophage polarization.
Liao R and 11 others. Bioact Mater, 2025. Cited by 42 papers, by iCite.
Cite this record
ConductScience Library. Inhalable and bioactive lipid-nanomedicine based on bergapten for targeted acute lung injury therapy via orchestrating macrophage polarization. Papers, record 39411684. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39411684
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inhalable and bioactive lipid-nanomedicine based on bergapten for targeted acute lung injury therapy via orchestrating macrophage polarization.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References52
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29466596 | Acute Respiratory Distress Syndrome: Advances in Diagnosis and Treatment. | JAMA | 2018 | https://conductscience.org/library/papers/29466596 | PubMed |
| 2 | 36037505 | Hybrid Biomimetic Nanovesicles to Drive High Lung Biodistribution and Prevent Cytokine Storm for ARDS Treatment. | ACS Nano | 2022 | https://conductscience.org/library/papers/36037505 | PubMed |
| 3 | 36069260 | Spatiotemporally Targeted Polypeptide Nanoantidotes Improve Chemotherapy Tolerance of Cisplatin. | Angew Chem Int Ed Engl | 2022 | https://conductscience.org/library/papers/36069260 | PubMed |
| 4 | 33547233 | Delivery of mRNA vaccine with a lipid-like material potentiates antitumor efficacy through Toll-like receptor 4 signaling. | Proc Natl Acad Sci U S A | 2021 | https://conductscience.org/library/papers/33547233 | PubMed |
| 5 | 21761867 | Adverse biophysical effects of hydroxyapatite nanoparticles on natural pulmonary surfactant. | ACS Nano | 2011 | https://conductscience.org/library/papers/21761867 | PubMed |
| 6 | 32863203 | Targeting NOX4 alleviates sepsis-induced acute lung injury via attenuation of redox-sensitive activation of CaMKII/ERK1/2/MLCK and endothelial cell barrier dysfunction. | Redox Biol | 2020 | https://conductscience.org/library/papers/32863203 | PubMed |
| 7 | 30872586 | Acute respiratory distress syndrome. | Nat Rev Dis Primers | 2019 | https://conductscience.org/library/papers/30872586 | PubMed |
| 8 | 33945618 | COVID-19 vaccines induce severe hemolysis in paroxysmal nocturnal hemoglobinuria. | Blood | 2021 | https://conductscience.org/library/papers/33945618 | PubMed |
| 9 | 38590795 | Edaravone-loaded poly(amino acid) nanogel inhibits ferroptosis for neuroprotection in cerebral ischemia injury. | Asian J Pharm Sci | 2024 | https://conductscience.org/library/papers/38590795 | PubMed |
| 10 | 39091384 | Brain-Targeted Drug Delivery Platforms for Ischemic Stroke Therapy. | BME Front | 2024 | https://conductscience.org/library/papers/39091384 | PubMed |
| 11 | 33977080 | Nanomedicine for acute respiratory distress syndrome: The latest application, targeting strategy, and rational design. | Acta Pharm Sin B | 2021 | https://conductscience.org/library/papers/33977080 | PubMed |
| 12 | 34311538 | Natural molecule Munronoid I attenuates LPS-induced acute lung injury by promoting the K48-linked ubiquitination and degradation of TAK1. | Biomed Pharmacother | 2021 | https://conductscience.org/library/papers/34311538 | PubMed |
| 13 | 34366849 | Glycoproteins From Rabdosia japonica var. glaucocalyx Regulate Macrophage Polarization and Alleviate Lipopolysaccharide-Induced Acute Lung Injury in Mice via TLR4/NF-κB Pathway. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34366849 | PubMed |
| 14 | 24039257 | Novel concepts of acute lung injury and alveolar-capillary barrier dysfunction. | Am J Physiol Lung Cell Mol Physiol | 2013 | https://conductscience.org/library/papers/24039257 | PubMed |
| 15 | 36583377 | Interactions of Inhaled Liposome with Macrophages and Neutrophils Determine Particle Biofate and Anti-Inflammatory Effect in Acute Lung Inflammation. | ACS Appl Mater Interfaces | 2023 | https://conductscience.org/library/papers/36583377 | PubMed |
| 16 | 22975080 | Altered lung function relates to inflammation in an acute LPS mouse model. | Pulm Pharmacol Ther | 2012 | https://conductscience.org/library/papers/22975080 | PubMed |
| 17 | 35346768 | The replacement of helper lipids with charged alternatives in lipid nanoparticles facilitates targeted mRNA delivery to the spleen and lungs. | J Control Release | 2022 | https://conductscience.org/library/papers/35346768 | PubMed |
| 18 | 37849509 | Nanoantidotes: A Detoxification System More Applicable to Clinical Practice. | BME Front | 2023 | https://conductscience.org/library/papers/37849509 | PubMed |
| 19 | 30078618 | Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial. | Lancet Respir Med | 2018 | https://conductscience.org/library/papers/30078618 | PubMed |
| 20 | 33007416 | Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms. | Pharmacol Res | 2021 | https://conductscience.org/library/papers/33007416 | PubMed |
Cited by37
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42985531 | Inhaled Nanomedicines for Lung Diseases and Injuries: Pharmacological Advances and Clinical Translation. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42985531 | PubMed |
| 42761950 | Nanomedicine for Acute Respiratory Distress Syndrome: From Pathophysiological Mechanisms and Disease Heterogeneity to Precision Therapy. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42761950 | PubMed |
| 42654124 | Bergapten as a Multifunctional Phytochemical in Cancer Therapy: Mechanistic Insights, Pharmacokinetics, and Possible Nanotechnology-Enabled Formulation Strategies. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42654124 | PubMed |
| 42388220 | Advanced Multiscale Inhalation Platforms for Treatment of Pulmonary Diseases. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42388220 | PubMed |
| 42338572 | Small intracellular vesicle-liposome fusogenic nanoplatform sIVs-LPs@Hes: Nebulized delivery targeting pulmonary inflammatory microenvironment to improve ALI. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42338572 | PubMed |
| 42293730 | A safe and anti-inflammatory plant-derived nanovesicle platform for targeted delivery in acute lung injury. | Bioact Mater | 2026 | https://conductscience.org/library/papers/42293730 | PubMed |
| 42292702 | Bergapten attenuates oxidative stress and neuroinflammation to promote the survival and neuronal differentiation of neural stem/progenitor cells after ischemic insult. | Biochem Biophys Rep | 2026 | https://conductscience.org/library/papers/42292702 | PubMed |
| 42253924 | Acute Lung Injury: From Molecular Circuits to System-Level Therapeutics. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42253924 | PubMed |
| 42213091 | An Inhalable Apoptosis-Mimicking Functionalized Carbon Dots-Methylprednisolone Nanomedicine for Synergistic Therapy in Acute Lung Injury. | Small | 2026 | https://conductscience.org/library/papers/42213091 | PubMed |
| 41969646 | Inhaled formulations for bacterial pneumonia: Strategies and advances in drug delivery. | Bioact Mater | 2026 | https://conductscience.org/library/papers/41969646 | PubMed |
| 41909672 | Selective JAK2 inhibition by TG101209 reprograms macrophage polarization and alleviates acute lung injury. | Front Immunol | 2026 | https://conductscience.org/library/papers/41909672 | PubMed |
| 41884518 | Inhalable PD-L1-engineered hybrid cellular vesicles suppress excessive neutrophil activation and restore mitochondrial homeostasis to alleviate ischemia-reperfusion lung injury and pneumonia. | Bioact Mater | 2026 | https://conductscience.org/library/papers/41884518 | PubMed |
| 41782990 | Hyaluronic acid engineered melanin-MOF nanoreactor synergistically remodeling redox and immune homeostasis for targeted acute lung injury therapy. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/41782990 | PubMed |
| 41686220 | IFIT3 stabilizes STING via USP18 to drive M1 macrophage polarization and early inflammation in acute lung injury. | Cell Mol Life Sci | 2026 | https://conductscience.org/library/papers/41686220 | PubMed |
| 41677655 | Engineered CCR2 Cell Membrane-Wrapped Cepharanthine Liposomes for Potential Targeted Attenuation of Acute Lung Injury. | Cells | 2026 | https://conductscience.org/library/papers/41677655 | PubMed |
| 41647999 | Liposomes as carriers for garlic oil delivery to increase anti-inflammatory and antioxidant activities in mice with ALI. | Exp Biol Med (Maywood) | 2026 | https://conductscience.org/library/papers/41647999 | PubMed |
| 41613243 | Low-concentration cholesterol modification enhances Clematis filamentosa Dunn-derived extracellular vesicle-mediated macrophage polarization regulation for acute lung injury therapy. | RSC Adv | 2026 | https://conductscience.org/library/papers/41613243 | PubMed |
| 41584355 | Inhalable songorine-integrated lipid nanomedicine for targeted ARDS therapy via repairing endothelial barrier and inactivating NLRP3 inflammasome. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/41584355 | PubMed |
| 41574664 | Advances in the mechanisms of the NLRP3 inflammasome in sepsis‑induced cardiomyopathy and targeted therapeutic studies (Review). | Mol Med Rep | 2026 | https://conductscience.org/library/papers/41574664 | PubMed |
| 41465505 | A Narrative Review on the Antitumoral Effects of Selected Mediterranean Plant Products from Southern Italy. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41465505 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39411684
GET https://conductscience.org/api/papers/v1/39411684/references?page=2